Evidence map›Paper›PMID 19684018›Full record

ArticleThe Journal of biological chemistry2009

Human copper transporter 1 lacking O-linked glycosylation is proteolytically cleaved in a Rab9-positive endosomal compartment.

Edward B Maryon, Jing Zhang, John W Jellison, Jack H Kaplan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Balancing cellular copper levels via the post-translational regulation of copper transport.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Characterization of a monoclonal antibody capable of reliably quantifying expression of human Copper Transporter 1 (hCTR1).Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2014
    Article
  13. Article
  14. A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment.International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2013
    Article
  15. Article
  16. Article
  17. Polymorphic transporters and platinum pharmacodynamics.Drug metabolism and pharmacokinetics · 2013
    Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Edward B MaryonDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607.
Jing ZhangDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607.
John W JellisonDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607.
Jack H KaplanDepartment of Biochemistry and Molecular Genetics, University of Illinois, Chicago, Illinois 60607. Electronic address: kaplanj@uic.edu.
University of Illinois Chicago · US

Funding

The role of transferrin receptor 2 in iron homeostasisP01GM067166 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI UNGER, VINZENZ · 2003 to 2013
$14.6M
NIGMS NIH HHS P01 GM 067166NIGMS NIH HHS P01 GM067166
6 · The paper itself

Abstract

The human copper transporter hCTR1 is a homotrimer composed of a plasma membrane protein of 190 amino acids that contains three transmembrane segments. The extracellular 65-amino acid amino terminus of hCTR1 contains both N-linked (at Asn(15)) and O-linked (at Thr(27)) sites of glycosylation. If O-glycosylation at Thr(27) is prevented, hCTR1 is efficiently cleaved, removing approximately 30 amino acids from the amino terminus. We have now investigated (i) the site of this cleavage, determining which peptide bonds are cleaved, (ii) the mechanism by which glycosylation prevents cleavage, and (iii) where in the cell the proteolytic cleavage takes place. Cleavage occurs in the sequence Ala-Ser-His-Ser-His (residues 29-33), which does not contain previously recognized protease cleavage sites. Using a series of hCTR1 mutants, we show that cleavage occurs preferentially between residues Ala(29)-Ser(30)-His(31). We also show that the O-linked polysaccharide at Thr(27) blocks proteolysis due to its proximity to the cleavage site. Moving the cleavage site away from the Thr(27) polysaccharide by insertion of as few as 5 amino acids allows cleavage to occur in the presence of glycosylation. Imaging studies using immunofluorescence in fixed cells and a functional green fluorescent protein-tagged hCTR1 transporter in live cells showed that the cleaved peptide accumulates in punctate structures in the cytoplasm. These puncta overlap compartments were stained by Rab9, indicating that hCTR1 cleavage occurs in a late endosomal compartment prior to delivery of the transporter to the plasma membrane.

Indexed as

Amino Acid SequenceAnimalsCation Transport ProteinsCell LineCopperCopper Transporter 1EndosomesGlycosylationHumansMolecular Sequence DataMutagenesis, Site-DirectedProtease InhibitorsProtein Structure, Secondaryrab GTP-Binding ProteinsRecombinant Fusion ProteinsCation Transport ProteinsCopperCopper Transporter 1Protease InhibitorsRAB9A protein, humanrab GTP-Binding ProteinsRecombinant Fusion ProteinsSLC31A1 protein, human

Identifiers

PMID19684018
PMCPMC2788861
OpenAlexW2037078303

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.